...
首页> 外文期刊>Hypertension in pregnancy: Official journal of the International Society for the Study of Hypertension in Pregnancy >Evaluation of red blood cell deformability and uterine blood flow in pregnant women with preeclampsia or iugr and reduced uterine blood flow following the intravenous application of magnesium.
【24h】

Evaluation of red blood cell deformability and uterine blood flow in pregnant women with preeclampsia or iugr and reduced uterine blood flow following the intravenous application of magnesium.

机译:评估先兆子痫或iugr孕妇以及静脉内施用镁后子宫血流减少的孕妇的红细胞变形性和子宫血流。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: Red blood cells (RBC) deformability is one of the factors determining microcirculation. In preeclampsia (PE) and some cases of intrauterine growth restriction (IUGR), RBC deformability and, consequently, microcirculation appear to be impaired. Magnesium sulfate is administered to reduce the risk of seizures in PE. The aim of our study was to detect the effect of 24-hour intravenous (IV) magnesium on RBC deformability and on uterine artery blood flow in pregnant patients with preeclampsia or IUGR and pathologic uterine blood flow. METHODS: Magnesium IV (1 g/h) was administered to 25 pregnant women with reduced uterine blood flow for a period of at least 24 hours. The RBC deformability was measured by uterine artery Doppler. Measurements were taken before the start of magnesium therapy and 24 h later. Magnesium plasma levels were measured at the same time. RESULTS: High plasma levels of magnesium improve RBC deformability from E = 0.109 (SD +/- 0.023) to E = 0.115 (SD +/- 0.021) after 24 h IV magnesium (p = 0.043). There is no correlation of E to the plasma magnesium level either before or after 24 h magnesium treatment. Blood volume flow in the uterine arteries increased significantly from 5.09 mL/s (SD +/- 3.03) to 10.02 mL/s (SD +/- 5.86) after 24 h magnesium (p = 0.0002). The differences in the resistance index do not significantly differ from 0 (p = 0.46). CONCLUSION: A high IV dosage of magnesium over a period of 24 hours dilates the uterine arteries of pregnant women with PE and/or IUGR, reduces uterine blood flow and improves the deformability of RBC. Both parameters enhance the oxygen supply to the fetus, a clinical parameter in these pregnancies. Thus magnesium might not only be effective as phrophylaxis against seizures but also in cases of IUGR with a reduced uterine blood flow. The clinically observed beneficial effect of magnesium in PE could be due to the improved blood supply for the fetus.
机译:目的:红细胞(RBC)的变形性是决定微循环的因素之一。在子痫前期(PE)和某些宫内生长受限(IUGR)的情况下,RBC的可变形性以及微循环似乎受损。服用硫酸镁可减少PE发作的风险。我们研究的目的是检测妊娠先兆子痫或IUGR患者的24小时静脉内(IV)镁对RBC变形性和子宫动脉血流量以及病理性子宫血流量的影响。方法:对25名子宫血流减少的孕妇给予静脉注射镁(1 g / h)至少24小时。通过子宫动脉多普勒测量RBC的可变形性。在开始镁治疗之前和之后24小时进行测量。同时测量镁血浆水平。结果:静脉内注射镁24小时后,高血浆镁水平可改善RBC的变形能力,从E = 0.109(SD +/- 0.023)到E = 0.115(SD +/- 0.021)(p = 0.043)。在24小时镁处理之前或之后,E与血浆镁水平没有相关性。镁注射24小时后,子宫动脉的血流量从5.09 mL / s(SD +/- 3.03)显着增加到10.02 mL / s(SD +/- 5.86)(p = 0.0002)。电阻指数的差异与0并无显着差异(p = 0.46)。结论:高剂量的镁在24小时内可以扩张PE和/或IUGR孕妇的子宫动脉,减少子宫血流量并改善RBC的变形能力。这两个参数都增强了胎儿的氧气供应,这是这些怀孕的临床参数。因此,镁不仅可以有效地预防癫痫发作,还可以在宫内血流减少的IUGR患者中使用。临床上观察到的镁在PE中的有益作用可能是由于胎儿血液供应的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号